The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

Abstract Background Patients with fibrotic interstitial lung disease (FILD) often experience gas exchange abnormalities and ventilatory limitations, resulting in reduced exercise capacity. High-flow nasal cannula (HFNC) oxygen therapy is a novel treatment, whose physiological beneficial effects have...

Full description

Bibliographic Details
Main Authors: Atsushi Suzuki, Masahiko Ando, Tomoki Kimura, Kensuke Kataoka, Toshiki Yokoyama, Eiichi Shiroshita, Yasuhiro Kondoh
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Pulmonary Medicine
Subjects:
Fibrotic interstitial lung disease
High-flow nasal cannula
Oxygen therapy
Exercise capacity
Pulmonary rehabilitation
Health status
Online Access:http://link.springer.com/article/10.1186/s12890-020-1093-2

Internet

http://link.springer.com/article/10.1186/s12890-020-1093-2

Similar Items